Voyager Therapeutics, Inc. (VYGR)
1 Item 5.02 filing since 2026-10-21 · roles: CEO. Nasdaq. Biological Products, (No Diagnostic Substances). State: MA.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 40 | 2026-10-21 | Retirement announced | CEO | subscribers | — | Voyager Therapeutics, Inc. (VYGR): CEO Alfred W. Sandrock, Jr., M.D., Ph.D. to retire |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works